Your browser doesn't support javascript.
loading
N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
Thorneloe, Kevin S; Sulpizio, Anthony C; Lin, Zuojun; Figueroa, David J; Clouse, Angela K; McCafferty, Gerald P; Chendrimada, Tim P; Lashinger, Erin S R; Gordon, Earl; Evans, Louise; Misajet, Blake A; Demarini, Douglas J; Nation, Josephine H; Casillas, Linda N; Marquis, Robert W; Votta, Bartholomew J; Sheardown, Steven A; Xu, Xiaoping; Brooks, David P; Laping, Nicholas J; Westfall, Timothy D.
Afiliação
  • Thorneloe KS; Cardiovascular and Urogenital Centre of Excellence in Drug Discovery, GlaxoSmithKline Pharmaceuticals, 709 Swedeland Road, King of Prussia, PA 19406, USA. Kevin.S.Thorneloe@gsk.com
J Pharmacol Exp Ther ; 326(2): 432-42, 2008 Aug.
Article em En | MEDLINE | ID: mdl-18499743

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Urodinâmica / Bexiga Urinária / Urotélio / Canais de Cátion TRPV / Leucina / Contração Muscular Limite: Animals Idioma: En Ano de publicação: 2008 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Urodinâmica / Bexiga Urinária / Urotélio / Canais de Cátion TRPV / Leucina / Contração Muscular Limite: Animals Idioma: En Ano de publicação: 2008 Tipo de documento: Article